Department of Internal Medicine and Gerontology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
J Hum Hypertens. 2010 Aug;24(8):538-44. doi: 10.1038/jhh.2009.97. Epub 2009 Dec 17.
Endothelin-1 (ET-1) and oxidative stress are involved in the development of hypertension-induced cardiovascular complications. The aim of this study was to evaluate the relationship between plasma ET-1 level and plasma antioxidant capacity and carotid atherosclerosis. In 61 treated patients with hypertension (44 women, 35 diabetics, mean age 72.4+/-7.2 years) medical histories, ambulatory blood pressure, blood tests (glucose, creatinine, cholesterol, haemoglobin A1c (HbA1c), ET-1) and common carotid artery intima-media thickness (CCA-IMT) measurement were carried out. Plasma antioxidant capacity was assessed by the ferric-reducing ability of plasma (FRAP). Subjects with diabetes presented with higher concentrations of glucose (7.01+/-2.3 vs 5.14+/-0.6 mmol l(-1), P<0.001), HbA1c (7.75+/-2.1 vs 6.1+/-1.2%, P<0.001) and ET-1 (1.36+/-0.53 vs 1.01+/-0.4 pg ml(-1), P<0.01), and lower cholesterol level (5.02+/-0.8 vs 5.86+/-1.3 mmol l(-1), P<0.01). A significant positive correlation between CCA-IMT and ET-1 plasma concentration (r=0.40, P<0.001) and reverse relationship between CCA-IMT and FRAP (r=-0.36, P<0.01) was observed. In a stepwise regression analysis, after adjustment for all confounders, CCA-IMT was independently influenced by age, systolic blood pressure (SBP), HbA1c and ET-1. When FRAP was included in the regression model, CCA-IMT was significantly influenced by age, FRAP, HbA1c and SBP. ET-1 promotes the increase in CCA-IMT contributing to the development of end-organ damage. Plasma antioxidant capacity may modulate this deleterious effect, but whether better antioxidant defence may prevent against the development of atherosclerosis remains to be elucidated.
内皮素-1(ET-1)和氧化应激参与了高血压引起的心血管并发症的发展。本研究的目的是评估血浆 ET-1 水平与血浆抗氧化能力和颈动脉粥样硬化之间的关系。在 61 名接受治疗的高血压患者(44 名女性,35 名糖尿病患者,平均年龄 72.4+/-7.2 岁)中,进行了病史、动态血压、血液检查(血糖、肌酐、胆固醇、糖化血红蛋白(HbA1c)、ET-1)和颈总动脉内膜-中层厚度(CCA-IMT)测量。通过血浆铁还原能力(FRAP)评估血浆抗氧化能力。糖尿病患者的血糖(7.01+/-2.3 与 5.14+/-0.6 mmol l(-1),P<0.001)、HbA1c(7.75+/-2.1 与 6.1+/-1.2%,P<0.001)和 ET-1(1.36+/-0.53 与 1.01+/-0.4 pg ml(-1),P<0.01)浓度较高,胆固醇水平较低(5.02+/-0.8 与 5.86+/-1.3 mmol l(-1),P<0.01)。CCA-IMT 与 ET-1 血浆浓度呈显著正相关(r=0.40,P<0.001),与 FRAP 呈负相关(r=-0.36,P<0.01)。在逐步回归分析中,调整所有混杂因素后,CCA-IMT 独立受年龄、收缩压(SBP)、HbA1c 和 ET-1 影响。当 FRAP 纳入回归模型时,CCA-IMT 显著受年龄、FRAP、HbA1c 和 SBP 影响。ET-1 促进 CCA-IMT 增加,导致终末器官损伤。血浆抗氧化能力可能调节这种有害作用,但更好的抗氧化防御是否能预防动脉粥样硬化的发展仍有待阐明。